Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.4401
Delayed Data
As of Oct 16
 +0.01 / +2.33%
Today’s Change
0.29
Today|||52-Week Range
1.16
-30.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues8.5M3.4M580.0K611.6K
 
 
 
 
 
Cost of Goods Sold909.5K242.3K0.000.00
 
 
 
Depreciation And Amortization111.5K122.5K86.5K70.5K
 
 
 
 
 
 
Operating ExpensesGross Income7.5M3.0M493.5K541.1K
 
 
 
 
 
General Expenses4.1M5.4M3.6M4.3M
 
 
 
 
 
Research And Development1.3M2.4M705.3K1.2M
 
 
 
 
 
Total Operating Expenses5.1M5.8M3.7M4.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.4M-2.4M-3.1M-3.7M
 
 
 
 
 
Extraordinary Credit0.001.1M140.5K12.9K
 
 
 
 
Extraordinary Charge-839.3K0.00-1.3M-394.0K
 
 
 
 
Interest Expense On Debt2.6M2.6M0.000.00
 
 
 
Other Expenses-12.5K22.0K-21.6K-722.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-59.5K-3.9M-4.3M-4.8M
 
 
 
 
 
Income Taxes0.000.00-1.5M-1.6M
 
 
 
Minority Interest-159.00-132.00-202.00-33.00
 
 
 
 
 
Discontinued Operations0.000.00-255.9K-82.4K
 
 
 
Extraordinary Items0.000.0088.7M-2.0M
 
 
 
Net Income-59.4K-3.9M-3.1M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.5M155.5M160.4M161.9M
 
 
 
 
 
Shares To Calculate EPS Diluted155.5M155.5M164.9M161.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.02$0.52-$0.03
 
 
 
 
EPS Diluted-$0.00-$0.02-$0.02-$0.02